Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

NCT03703492 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Ductal Carcinoma in Situ - Category

Interventions

DRUG: (18F)FES
DRUG: Gadobenate dimeglumine

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]